Segall Bryant & Hamill, LLC Pfizer Inc Transaction History

Segall Bryant & Hamill, LLC

$5.57 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $3.11 Million - $3.63 Million	-96,821 Reduced 15.11%	543,996 $18 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $3.25 Million - $3.76 Million	-89,984 Reduced 12.31%	640,817 $23.5 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $263,243 - $342,704	-6,683 Reduced 0.91%	730,801 $29.8 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $568,468 - $742,072	-13,616 Reduced 1.81%	737,484 $37.8 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $362,551 - $442,584	-8,285 Reduced 1.09%	751,100 $32.9 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $180,862 - $214,445	-3,887 Reduced 0.51%	759,385 $39.8 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $538,431 - $667,184	-11,769 Reduced 1.52%	763,272 $39.5 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $458,404 - $679,507	-11,094 Reduced 1.41%	775,041 $45.8 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $280,362 - $360,150	-7,143 Reduced 0.9%	786,135 $33.8 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $5.96 Million - $6.75 Million	-165,838 Reduced 17.29%	793,278 $31.1 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $1.41 Million - $1.59 Million	-42,087 Reduced 4.2%	959,116 $34.7 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $642,389 - $816,854	-19,193 Reduced 1.88%	1,001,203 $36.9 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $682,402 - $800,614	21,493 Added 2.15%	1,020,396 $35.5 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $1.43 Million - $1.73 Million	-47,351 Reduced 4.53%	998,903 $31 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $1.26 Million - $1.8 Million	-46,539 Reduced 4.26%	1,046,254 $32.4 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $1.41 Million - $1.6 Million	-42,908 Reduced 3.78%	1,092,793 $40.6 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $1.4 Million - $1.81 Million	-43,014 Reduced 3.65%	1,135,701 $38.7 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $655,655 - $736,149	-17,730 Reduced 1.48%	1,178,715 $0
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $467,325 - $513,434	-12,462 Reduced 1.03%	1,196,445 $0
Q4 2018 Feb 15, 2019	SELL	$38.47 - $43.86 $455,946 - $519,828	-11,852 Reduced 0.97%	1,208,907 $50.1 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $710,909 - $862,289	-20,624 Reduced 1.66%	1,220,759 $0
Q2 2018 Aug 08, 2018	BUY	$32.98 - $35.16 $16.8 Million - $17.9 Million	509,650 Added 69.65%	1,241,383 $0
Q1 2018 May 16, 2018	SELL	$31.91 - $37.02 $176,430 - $204,683	-5,529 Reduced 0.75%	731,733 $0
Q4 2017 Feb 15, 2018	SELL	$33.26 - $35.29 $101,808 - $108,022	-3,061 Reduced 0.41%	737,262 $0
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $23 Million - $25.3 Million	740,323	740,323 $0

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.51 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.93 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.48 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account